Granules India shares tumble almost 8% after USFDA issues warning letter for its Gagillapur facility | Stock Market News
Source: Live Mint Shares of Granules India tumbled nearly 8 percent in intra-day trade on February 28, 2025, after the United States Food and Drug Administration (US FDA) issued a warning letter to the company’s Gagillapur facility. US FDA Warning and Regulatory Impact In a regulatory filing, Granules India confirmed that the US FDA issued…